Interleukin-13 in asthma

Some time ago, the Th2 cytokine, interleukin (IL)-13, was identified as a critical regulator of the allergic response. Initial studies in animal models of disease provided compelling evidence that IL-13, independent from other Th2 cytokines, was necessary and sufficient to induce all features of allergic asthma. This contention was supported in human disease when strong associations between IL-13 levels and genetic polymorphisms in the IL-13 gene and disease correlates were found. With the preponderance of evidence continuing to support the importance of IL-13 in allergic disorders, attention is now turned towards understanding the mechanisms by which this cytokine may mediate the pathophysiologic features of allergic disease. The emerging paradigm is that IL-13 induces features of the allergic response via its actions on epithelial and smooth muscle cells not through traditional effector pathways involving eosinophils and IgE-mediated events. In light of recent developments, this review will explore our current understanding of the role of IL-13 in the pathogenesis of allergy and asthma with a particular focus on new insights into the mechanisms by which IL-13 induces the features of asthma.

[1]  D. Sheppard,et al.  Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma , 2002, Nature Medicine.

[2]  C. Bizer,et al.  Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases1 , 2002, The Journal of Immunology.

[3]  R. Coffman,et al.  New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-251 , 2002, The Journal of Immunology.

[4]  P. Foster,et al.  Intrinsic Defect in T Cell Production of Interleukin (IL)-13 in the Absence of Both IL-5 and Eotaxin Precludes the Development of Eosinophilia and Airways Hyperreactivity in Experimental Asthma , 2002, The Journal of experimental medicine.

[5]  R. Puri,et al.  Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. , 2002, The Journal of allergy and clinical immunology.

[6]  P. Romeo,et al.  Interleukin-13 Gene Expression Is Regulated by GATA-3 in T Cells , 2002, The Journal of Biological Chemistry.

[7]  D. Romberger,et al.  Th2 cytokine regulation of type I collagen gel contraction mediated by human lung mesenchymal cells. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[8]  Tak H. Lee,et al.  Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. , 2002, American journal of respiratory and critical care medicine.

[9]  R. Panettieri,et al.  IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[10]  S. Rennard,et al.  Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma. , 2002, American journal of respiratory cell and molecular biology.

[11]  E. Silverman,et al.  Lack of association between a polymorphism in the interleukin‐13 gene and total serum immunoglobulin E level among nuclear families in Costa Rica , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  M. Grunstein,et al.  IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[13]  A. Yamada,et al.  Dysregulation of IL-13 Production by Cord Blood CD4+ T Cells Is Associated with the Subsequent Development of Atopic Disease in Infants , 2002, Pediatric Research.

[14]  H. Danahay,et al.  Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[15]  D. Corry,et al.  The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. , 2002, American journal of respiratory cell and molecular biology.

[16]  D. Postma,et al.  Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. , 2002, American journal of human genetics.

[17]  R. Flavell,et al.  Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. , 2002, The Journal of clinical investigation.

[18]  B. Vargaftig,et al.  Granulocyte depletion and dexamethasone differentially modulate airways hyperreactivity, inflammation, mucus accumulation, and secretion induced by rmIL-13 or antigen. , 2002, American journal of respiratory cell and molecular biology.

[19]  A Coste,et al.  IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. , 2001, The Journal of clinical investigation.

[20]  L. Martin,et al.  Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha. , 2001, American journal of respiratory cell and molecular biology.

[21]  M. Leach,et al.  IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. , 2001, Immunity.

[22]  T. Arinami,et al.  Haplotypes of the 5' region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma. , 2001, Human immunology.

[23]  D. Umetsu,et al.  Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity1 , 2001, The Journal of Immunology.

[24]  I. Ho,et al.  The Cell Type-Specific Expression of the Murine IL-13 Gene Is Regulated by GATA-31 , 2001, The Journal of Immunology.

[25]  P. Foster,et al.  Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin. , 2001, American journal of respiratory cell and molecular biology.

[26]  P. Foster,et al.  IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. , 2001, The Journal of allergy and clinical immunology.

[27]  C. Lam,et al.  A polymorphism in the coding region of interleukin‐13 gene is associated with atopy but not asthma in Chinese children , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[28]  N. Osna,et al.  Regulation of IL-13 production by histamine in cloned murine T helper type 2 cells. , 2001, International immunopharmacology.

[29]  Y. Zhou,et al.  Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. , 2001, American journal of respiratory cell and molecular biology.

[30]  R. Djukanović,et al.  The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. , 2001, American journal of respiratory cell and molecular biology.

[31]  D. Postma,et al.  Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. , 2001, American journal of respiratory cell and molecular biology.

[32]  Edward M. Rubin,et al.  Deletion of a coordinate regulator of type 2 cytokine expression in mice , 2001, Nature Immunology.

[33]  J. Kinet,et al.  Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. , 2001, American journal of respiratory and critical care medicine.

[34]  J. Westwick,et al.  Therapeutic Effect of IL-13 Immunoneutralization During Chronic Experimental Fungal Asthma1 , 2001, The Journal of Immunology.

[35]  Yukio Fujisawa,et al.  Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Foster,et al.  IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. , 2001, Journal of immunology.

[37]  R. Ames,et al.  Cutting Edge: Guinea Pigs with a Natural C3a-Receptor Defect Exhibit Decreased Bronchoconstriction in Allergic Airway Disease: Evidence for an Involvement of the C3a Anaphylatoxin in the Pathogenesis of Asthma1 , 2000, The Journal of Immunology.

[38]  B. Ma,et al.  Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. , 2000, The Journal of clinical investigation.

[39]  Bao Lu,et al.  A role for the C3a anaphylatoxin receptor in the effector phase of asthma , 2000, Nature.

[40]  S. Weiland,et al.  A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. , 2000, The Journal of allergy and clinical immunology.

[41]  K. Deichmann,et al.  Genetic variants of IL-13 signalling and human asthma and atopy. , 2000, Human molecular genetics.

[42]  T. Wynn,et al.  An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. , 1999, The Journal of clinical investigation.

[43]  E. Groot,et al.  An IL-13 promoter polymorphism associated with increased risk of allergic asthma , 1999, Genes and Immunity.

[44]  R. Homer,et al.  Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. , 1999, Journal of immunology.

[45]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[46]  T. Mosmann,et al.  Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. , 1999, Journal of immunology.

[47]  D B Corry,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[48]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[49]  J. Bonnefoy,et al.  The distribution of IL‐13 receptor α1 expression on B cells, T cells and monocytes and its regulation by IL‐13 and IL‐4 , 1998, European journal of immunology.

[50]  L. Cohn,et al.  IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. , 1998, Journal of immunology.

[51]  R. Flavell,et al.  Expression of Interleukin 9 in the Lungs of  Transgenic Mice Causes Airway Inflammation, Mast Cell Hyperplasia, and Bronchial Hyperresponsiveness , 1998, The Journal of experimental medicine.

[52]  G. McKenzie,et al.  Impaired development of Th2 cells in IL-13-deficient mice. , 1998, Immunity.

[53]  P. Foster,et al.  A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. , 1998, Journal of immunology.

[54]  M. Wills-Karp,et al.  Signal Transducer and Activator of Transcription Factor 6 (Stat6)-deficient Mice Are Protected from Antigen-induced Airway Hyperresponsiveness and Mucus Production , 1998, The Journal of experimental medicine.

[55]  L. Cohn,et al.  IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. , 1998, Journal of immunology.

[56]  S. Durham,et al.  Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. , 1997, Journal of immunology.

[57]  S. Durham,et al.  Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. , 1997, The Journal of allergy and clinical immunology.

[58]  R. Martin,et al.  Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. , 1997, American journal of respiratory and critical care medicine.

[59]  F. Finkelman,et al.  Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. , 1997, The American journal of physiology.

[60]  B. Stripp,et al.  Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[61]  L. Lichtenstein,et al.  IL-13 expression at the sites of allergen challenge in patients with asthma. , 1995, Journal of immunology.

[62]  C. Bertrand,et al.  Interleukin-4 is required for the induction of lung Th2 mucosal immunity. , 1995, American journal of respiratory cell and molecular biology.

[63]  R. Coffman,et al.  Modulation of murine macrophage function by IL-13. , 1993, Journal of immunology.